Study tests combo of heart valve, lower dose of blood thinners

U.S. scientists are conducting an FDA-approved study to test the safety and efficacy of using lower dosages of anti-coagulants in patients with a mechanical heart valve from On-X Life Technologies. The On-X device may become the first heart valve approved for patients taking lower doses of blood-thinning drugs and could help improve quality of life, one of the researchers said.

View Full Article in:

Indianapolis Star (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN